191 related articles for article (PubMed ID: 34426560)
21. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
23. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
24. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
Zhou T; Gao Y
World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
[TBL] [Abstract][Full Text] [Related]
26. miR‑300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer‑binding factor 1 in hepatocellular carcinoma.
Chen Y; Guo Y; Li Y; Yang J; Liu J; Wu Q; Wang R
Int J Oncol; 2019 Apr; 54(4):1282-1294. PubMed ID: 30968150
[TBL] [Abstract][Full Text] [Related]
27. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
28. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X
Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236
[TBL] [Abstract][Full Text] [Related]
29. T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression.
Feng X; Yao W; Zhang Z; Yuan F; Liang L; Zhou J; Liu S; Song J
Oncol Res; 2018 Jul; 26(6):959-966. PubMed ID: 29295731
[TBL] [Abstract][Full Text] [Related]
30. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
31. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
32. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.
Li TE; Wang S; Shen XT; Zhang Z; Chen M; Wang H; Zhu Y; Xu D; Hu BY; Wei R; Zheng Y; Dong QZ; Qin LX
Front Immunol; 2020; 11():589997. PubMed ID: 33193421
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
34. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells.
Mattern J; Roghi CS; Hurtz M; Knäuper V; Edwards DR; Poghosyan Z
Sci Rep; 2019 Aug; 9(1):12540. PubMed ID: 31467400
[TBL] [Abstract][Full Text] [Related]
35. PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape.
Wei X; Yang W; Zhang F; Cheng F; Rao J; Lu L
Life Sci; 2020 Nov; 260():118476. PubMed ID: 32971102
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC
Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723
[TBL] [Abstract][Full Text] [Related]
37. High STRN Expression Promotes HCC Invasion and Migration but Not Cell Proliferation or Apoptosis through Facilitating Epithelial-Mesenchymal Transition.
Du QY; Yao JH; Zhou YC; Xu LJ; Zhao FY; Yang Y
Biomed Res Int; 2020; 2020():6152925. PubMed ID: 32280692
[TBL] [Abstract][Full Text] [Related]
38. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
39. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
40. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]